{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:24:57Z","timestamp":1792671897075,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1245\/s10434-020-08234-x","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T17:03:53Z","timestamp":1581354233000},"page":"2985-2996","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["The Pathologic Peritoneal Cancer Index (PCI) Strongly Differs From the Surgical PCI in Peritoneal Metastases Arising From Various Primary Tumors"],"prefix":"10.1245","volume":"27","author":[{"given":"Aditi","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yonemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazim","family":"Benzerdjeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loma","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suniti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mita","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakina","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bonnefoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"8234_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13193-018-0856-1","volume":"10","author":"PH Sugarbaker","year":"2019","unstructured":"Sugarbaker PH. Prevention and treatment of peritoneal metastases: a comprehensive review. Indian J Surg Oncol. 2019;10:3.","journal-title":"Indian J Surg Oncol."},{"key":"8234_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.\u00a0Cancer Treat Res.\u00a01996;82:359\u201374.","journal-title":"Cancer Treat Res."},{"key":"8234_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3978\/j.issn.2078-6891.2015.115","volume":"7","author":"RN Low","year":"2016","unstructured":"Low RN. Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.\u00a0J Gastrointest Oncol. 2016;7:58\u201371. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.115.","journal-title":"J Gastrointest Oncol."},{"key":"8234_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1148\/rg.292085189","volume":"29","author":"AD Levy","year":"2009","unstructured":"Levy AD,\u00a0Shaw JC,\u00a0Sobin LH. Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics.\u00a02009;29:347\u201373. https:\/\/doi.org\/10.1148\/rg.292085189.","journal-title":"Radiographics."},{"key":"8234_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ygyno.2012.11.007","volume":"128","author":"J Hynninen","year":"2013","unstructured":"Hynninen J, Lavonius M, Oksa S, Grenman S, Carpen O, Auranen A. Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy? Gynecol Oncol. 2013;128:229\u201332.","journal-title":"Gynecol Oncol."},{"key":"8234_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s13193-016-0497-1","volume":"7","author":"P Sammartino","year":"2016","unstructured":"Sammartino P, Biacchi D, Cornali T, et al. Proactive management for gastric, colorectal, and appendiceal malignancies: preventing peritoneal metastases with hyperthermic intraperitoneal chemotherapy (HIPEC).\u00a0Indian J Surg Oncol. 2016;7:215\u201324.","journal-title":"Indian J Surg Oncol."},{"key":"8234_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures.\u00a0Ann Surg. 1995;221:29\u201342.","journal-title":"Ann Surg."},{"key":"8234_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-019-00897-7","author":"A Bhatt","year":"2019","unstructured":"Bhatt A, Mishra S, Parikh L, et al. Essentials for pathological evaluation of peritoneal surface malignancies and synoptic reporting of cytoreductive surgery specimens: a review and evidence-based guide. Indian J Surg Oncol. 2019. https:\/\/doi.org\/10.1007\/s13193-019-00897-7.","journal-title":"Indian J Surg Oncol."},{"key":"8234_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ejso.2016.03.015","volume":"42","author":"L Villeneuve","year":"2016","unstructured":"Villeneuve L, Thivolet A, Bakrin N, et al. A new Internet tool to report peritoneal malignancy extent: PeRitOneal malignancy stage evaluation (PROMISE) application. Eur J Surg Oncol. 2016;42:877\u201382.","journal-title":"Eur J Surg Oncol."},{"key":"8234_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, et al A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40:14\u201326.","journal-title":"Am J Surg Pathol."},{"key":"8234_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/PAS.0b013e3182657186","volume":"37","author":"S-B Lim","year":"2013","unstructured":"Lim S-B, Hong S-M, Yu CS, et al. Prevalence and clinical significance of acellular mucin in locally advanced rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy. Am J Surg Pathol. 2013;37:47\u201352.","journal-title":"Am J Surg Pathol."},{"key":"8234_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/pp-2016-0011","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, Sempoux C, Detlefsen S, Carr NJ, Bibeau F. Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS).\u00a0Pleura Peritoneum. 2016;1:99\u2013107. https:\/\/doi.org\/10.1515\/pp-2016-0011.","journal-title":"Pleura Peritoneum."},{"key":"8234_CR13","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","volume":"22","author":"D Go\u00e9r\u00e9","year":"2015","unstructured":"Go\u00e9r\u00e9 D, Souadka A, Faron M, Cloutier AS, Viana B, Honor\u00e9 C, et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study.\u00a0Ann Surg Oncol.\u00a02015;22:2958\u201364.","journal-title":"Ann Surg Oncol."},{"key":"8234_CR14","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:2370\u20137.","journal-title":"Ann Surg Oncol."},{"key":"8234_CR15","doi-asserted-by":"publisher","first-page":"978394","DOI":"10.1155\/2013\/978394","volume":"2013","author":"Y Yonemura","year":"2013","unstructured":"Yonemura Y, Canbay E, Ishibashi H. Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy.\u00a0Sci World J.\u00a02013;2013:978394.","journal-title":"Sci World J."},{"key":"8234_CR16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","volume":"203","author":"RG da Silva","year":"2006","unstructured":"da Silva RG, Sugarbaker PH. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.\u00a0J Am Coll Surg.\u00a02006;203:878\u201386.","journal-title":"J Am Coll Surg."},{"key":"8234_CR17","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1245\/s10434-016-5211-6","volume":"23","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, van Oudheusden TR, Nieboer D, et al. Development of a prognostic nomogram for patients with peritoneally metastasized colorectal cancer treated with cytoreductive surgery and HIPEC.\u00a0Ann Surg Oncol.\u00a02016;23:4214\u201321.","journal-title":"Ann Surg Oncol."},{"key":"8234_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejso.2017.11.003","volume":"44","author":"A Llueca","year":"2018","unstructured":"Llueca A, Escrig J;\u00a0MUAPOS (Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery) working group. Prognostic value of peritoneal cancer index in primary advanced ovarian cancer. Eur J Surg Oncol.\u00a02018;44:163\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"8234_CR19","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.3802\/jgo.2018.29.e47","volume":"29","author":"AA Elzarkaa","year":"2018","unstructured":"Elzarkaa AA, Shaalan W, Elemam D, et al. Peritoneal cancer index as a predictor of survival in advanced-stage serous epithelial ovarian cancer: a prospective study.\u00a0J Gynecol Oncol. 2018;29:e47. https:\/\/doi.org\/10.3802\/jgo.2018.29.e47.","journal-title":"J Gynecol Oncol."},{"key":"8234_CR20","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","volume":"39","author":"N Bakrin","year":"2013","unstructured":"Bakrin N, Bereder JM, Decullier E, Classe JM, Msika S, Lorimier G, et al. Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.\u00a0Eur J Surg Oncol.\u00a02013;39:1435\u201343.","journal-title":"Eur J Surg Oncol."},{"key":"8234_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1245\/s10434-017-6315-3","volume":"25","author":"KI Votanopoulos","year":"2017","unstructured":"Votanopoulos KI, Bartlett D, Moran B, et al. PCI is not predictive of survival after complete CRS\/HIPEC in peritoneal dissemination from high-grade appendiceal primaries.\u00a0Ann Surg Oncol. 2017;25:674\u20138. https:\/\/doi.org\/10.1245\/s10434-017-6315-3.","journal-title":"Ann Surg Oncol."},{"key":"8234_CR22","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","volume":"23","author":"S Kusamura","year":"2016","unstructured":"Kusamura S, Torres Mesa PA, Cabras A, Baratti D, Deraco M. The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol.\u00a02016;23:1468\u201373.","journal-title":"Ann Surg Oncol."},{"key":"8234_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/02656736.2017.1320591","volume":"33","author":"KK Turaga","year":"2017","unstructured":"Turaga KK,\u00a0Deraco M,\u00a0Alexander HR. Current management strategies for peritoneal mesothelioma. Int J Hyperthermia.\u00a02017;33:579\u201381. https:\/\/doi.org\/10.1080\/02656736.2017.1320591.","journal-title":"Int J Hyperthermia."},{"key":"8234_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ejso.2012.01.001","volume":"38","author":"D Elias","year":"2012","unstructured":"Elias D, Souadka A, Fayard F, Mauguen A, Dumont F, Honore C, et al. Variation in the peritoneal cancer index scores between surgeons and according to when they are determined (before or after cytoreductive surgery). Eur J Surg Oncol.\u00a02012;38:503\u201308.","journal-title":"Eur J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08234-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-020-08234-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08234-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:07:21Z","timestamp":1612915641000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-020-08234-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["8234"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08234-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"10 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Olivier Glehen has received honoraria from Gamida Tech. Nazim Benzerdjeb has received honoraria from MSD, Pfizer, and AMARAPE (association created by patients with two rare diseases of the peritoneum: PMP and mesothelioma). The remaining authors have no conflicts of interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}